Bellicum Pharmaceuticals Inc
(NASDAQ : BLCM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.49%203.801.2%$408.08m
GILDGilead Sciences, Inc.
1.24%73.680.9%$399.35m
CELGCelgene Corporation
1.24%88.281.2%$343.33m
BIIBBiogen Inc.
0.81%337.091.2%$276.17m
ILMNIllumina, Inc.
2.06%354.373.5%$257.44m
REGNRegeneron Pharmaceuticals, Inc.
0.58%388.742.6%$211.47m
EXASExact Sciences Corporation
-1.08%72.5425.3%$196.54m
VRTXVertex Pharmaceuticals Incorporated
1.28%178.051.9%$161.92m
SRPTSarepta Therapeutics, Inc.
0.75%153.4916.4%$125.80m
AAgilent Technologies, Inc.
-0.20%68.941.5%$121.25m
ALXNAlexion Pharmaceuticals, Inc.
2.33%120.562.0%$110.00m
NKTRNektar Therapeutics
2.11%59.545.6%$97.99m
ALNYAlnylam Pharmaceuticals, Inc
1.86%95.099.7%$97.60m
BMRNBioMarin Pharmaceutical Inc.
1.60%99.724.4%$92.13m
INCYIncyte Corporation
1.36%67.932.5%$88.90m

Company Profile

Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. It uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.